Medical Ozone Generator MarketSize and Trends

The global medical ozone generator market is estimated to be valued at US$ 115.9 million in 2021 and is expected to exhibit a CAGR of 5.8 % during the forecast period (2021-2028).

Rising prevalence of cancer and other chronic diseases such as arthritis, wound healing, etc. is expected to drive the market growth during the forecast period.

Increasing prevalence of cancer and other chronic diseases is expected to drive the global medical ozone generator market growth over the forecast period. Ozone therapy helps to stop the growth of human cancer cells from breast, lung, and uterus by 40-90%. For instance, according to data published in World Health Organization in September 2021, stated that Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. The most common cancer cases in 2020 are breast (2.26 million cases), lung (2.21 million cases), colon and rectum (1.93 million cases), prostate (1.41 million cases), skin (non-melanoma) (1.20 million cases) and stomach (1.09 million cases).

Increase in the number of people suffering from skin conditions is expected to drive the market growth during the forecast period.

Increase in the number of people suffering from skin conditions is anticipated to drive growth of the global medical ozone generator market over the forecast period. For instance, according to an article published by Frontiers in 2020, the overall prevalence of acne among European aged 15–24 years was 57.8% (58.28% in males, 56.97% in females). Moreover, epidemiological survey of acne among undergraduates in the North East China showed that the total prevalence of acne among adolescents was 51.30% (52.74% in males, 49.65% in females)

Global Medical Ozone Generator Market– Impact of Coronavirus (COVID-19) Pandemic

The coronavirus (COVID 19) pandemic and lockdown in various countries across the globe have impacted the financial status of businesses in all sectors. Private healthcare sector is one of the sectors, which is majorly impacted by the COVID 19 pandemic. Coronavirus pandemic has negatively impacted the development, production, and supply of medical devices and also affected growth of the healthcare businesses of various companies across the globe, as COVID-19 pandemic has led to lockdown in several countries, globally. This lockdown has resulted in closure of industrial establishments, except manufacturing of essential commodities, and disruption in supply chain of the pharmaceuticals and kits for diagnostic and therapeutic use. Thus, COVID-19 pandemic has affected the economy in three main ways; 1) By directly affecting the production and demand; 2) By creating disruptions in distribution channels; and 3) By its financial impact on firms and financial markets. Supply chain and manufacturing activities in India, China, and the U.S. are disrupted due to global lockdown, while many countries such as Saudi Arabia, UAE, Egypt, and others are facing problems with regards to transportation of portable blue light therapy from one place to another